Alanylglutamine

丙氨酰谷氨酰胺

Report date: 2023/07/26 15:17:30
NME

Base Information

Drug NameAlanylglutamine
Drug Alias NameAlanyl Glutamine丙氨酰-L-谷氨酰胺Glutamine dipeptideL-丙氨酸-L-谷胺酰胺N(2)-L-丙氨酰-L-谷氨酰胺 +[23] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Parenteral NutritionDiarrhea +[11] 
Global Approved IndicationsGlutamine deficiency
Approved Indications in ChinaGlutamine deficiency
Original Approved Country/TerritoryGermany
Original Approved Date1995/04/01
Country/TerritoryUnited StatesGermanyEgypt +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active CompaniesFresenius AgEmmaus Life Sciences IncAssiut University +[4] 
Inactive CompaniesBeijing Suliman Pharmaceutical Technology Co LtdUniversidade Federal Do CearáInstitute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences +[4] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)DiarrheaDiverticulosis, Colonic +[6] 
Inactive IndicationsParenteral NutritionMalnutritionHeart Diseases +[5] 

Other Information

ATC CodeB05BA01B05XB02
Related LinksN/A